Vimarsana
Biggest News Aggregation in the World

Page 27 - Industry Classification Benchmark News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Industry Classification Benchmark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Industry Classification Benchmark Today - Breaking & Trending Today

Chesley Taft & Associates LLC Sells 712 Shares of iShares Biotechnology ETF (NASDAQ:IBB) - Vimarsana News

Chesley Taft & Associates LLC Sells 712 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Chesley Taft & Associates LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Get Rating) by 2.1% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 32,764 shares of the financial services provider’s stock after selling 712 shares during the period. Chesley Taft & […]

Source: wkrb13.com
8,697 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Bought by Clarus Wealth Advisors - Vimarsana News

8,697 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Bought by Clarus Wealth Advisors

Clarus Wealth Advisors acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Get Rating) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 8,697 shares of the financial services provider’s stock, valued at approximately $1,140,000. Several other institutional investors and […]

Source: wkrb13.com
Clarus Wealth Advisors Takes Position in iShares Biotechnology ETF (NASDAQ:IBB) - Vimarsana News

Clarus Wealth Advisors Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

Clarus Wealth Advisors bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Get Rating) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 8,697 shares of the financial services provider’s stock, valued at approximately $1,140,000. A number of other […]

Bank of New Hampshire Reduces Holdings in iShares Biotechnology ETF (NASDAQ:IBB) - Vimarsana News

Bank of New Hampshire Reduces Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Bank of New Hampshire decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Get Rating) by 10.3% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 5,006 shares of the financial services provider’s stock after selling 574 shares during the period. Bank of New Hampshire’s holdings […]

Source: wkrb13.com
First Financial Bank Trust Division Sells 141 Shares of iShares Biotechnology ETF (NASDAQ:IBB) - Vimarsana News

First Financial Bank Trust Division Sells 141 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

First Financial Bank Trust Division reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Get Rating) by 6.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,935 shares of the financial services provider’s stock after selling 141 shares during the […]